Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Heart muscle regeneration genes mapped

Researchers have uncovered insights into how stem cells develop and mature into heart muscle...

The cause of 2022's mpox outbreak revealed

Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...

New gene therapy treats liver disorder in growing children

Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...

Content from other channels on our network

$2.5m to double circuit breaker production in Adelaide

ARENA announces new clean energy startup funding

Peak body wants engineering expertise at the heart of the AI future

$26 million to fund new Australian iron technology

Yokogawa launches cyber resilience centre for SE Asia and Oceania

APPEX 2027 is now open for registrations

Facing the manufacturing workforce challenges of the future

Paving the way for success with plant-based ingredients

Baiada Poultry opens its multimillion-dollar processing plant in Tamworth

NewCold's $200m expansion of cold storage facility in Vic

$2.5m to double circuit breaker production in Adelaide

Long-term water security project proposed for Hunter region

Engineering sustainability from the ground up at Selfs Point STP

Complex solar installation for Adelaide wine venue

Australia's data centre plans can become a blueprint for the world